These include some genetic alterations that are more prevalent in other AML subtypes such as FLT3 internal tandem repeats, an MLL-AF9 fusion and mutations in CBL, KMT2A and NF1 genes. This evidence concerns the gene NF1 and acute myeloid leukemia.